HLN · Haleon plc ADR
United States · RS rating 60 · As of 2026-10-14
| Price | 9.68 USD |
|---|---|
| 1-day change | +2.5% |
| RS rating (overall / 1M / 3M / 12M) | 60 / 88 / 46 / 58 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 28 / 32 / 25 |
| Industry group (rank) | Medical-Generic Drugs (94) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -0.8% |
| Distance from 52-week high | +14.1% |
| Market cap (USD) | $42.4B |